21% of patients received different final diagnoses after second opinion

A study conducted by James Naessens, ScD, a healthcare policy researcher at Mayo Clinic, published in the Journal of Evaluation in Clinical Practice, showed how a second opinion can affect the final diagnoses of a patient’s condition.

When patients have an ambiguous or undiagnosed condition, it is common to refer to another physician for a second opinion. The additional insight can impact the final diagnosis, which was the focus of the the Mayo Clinic study.

“Effective and efficient treatment depends on the right diagnosis,” said Naessens. “Knowing that more than one out of every five referral patients may be completely [and] incorrectly diagnosed is troubling─not only because of the safety risks for these patients prior to correct diagnosis, but also because of the patients we assume are not being referred at all.”

Examining the difference in diagnostic outcomes, the study included 286 patients referred from their clinicians to Mayo Clinic’s General Internal Medicine Division from 2009 through 2010. Patients initial and final diagnoses were compared to measure diagnostic differences.

Results showed that only 12 percent of initial diagnoses were the same as the final ones. Two thirds (66 percent) of final diagnoses were improved. Also, in 21 percent of patients, the final conclusion differed significantly from the initial diagnoses. By showcasing the importance of a second opinion and additional insights on diagnoses, researchers hope to incorporate these finding in healthcare systems in order to reduce medical error.

“This may prevent identification of diagnostic error and could lead treatment delays, complications leading to more costly treatments or even patient harm or death,” said Naessens. “We want to encourage second opinions when the provider is not certain.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”